Corporate News     19-Sep-22
Indoco Remedies' AnaCipher CRO successfully clears USFDA audit
Indoco Remedies announced today that its Clinical Research Organisation, AnaCipher, located in Hyderabad, was inspected by the United States Food and Drug Administration from 12 to 16 September 2022. The clinical phase of inspection covered three BA/BE studies submitted by clients to the USFDA and was successfully concluded with zero 483s.
Previous News
  Indoco Remedies consolidated net profit declines 29.46% in the September 2023 quarter
 ( Results - Announcements 19-Oct-23   14:00 )
  Indoco Remedies consolidated net profit declines 42.10% in the December 2023 quarter
 ( Results - Announcements 23-Jan-24   13:34 )
  Indoco Remedies Q2 PAT slides 33% YoY to Rs 33 cr
 ( Hot Pursuit - 19-Oct-23   15:12 )
  Board of Indoco Remedies recommends Final Dividend
 ( Corporate News - 16-May-24   17:51 )
  Indoco Remedies to announce Quarterly Result
 ( Corporate News - 04-Jan-22   16:38 )
  Indoco Remedies to table results
 ( Corporate News - 11-Jan-24   11:27 )
  Indoco Remedies slides as Q3 PAT tumbles 28% YoY
 ( Hot Pursuit - 23-Jan-24   15:40 )
  Indoco Remedies to declare Quarterly Result
 ( Corporate News - 21-Oct-22   14:02 )
  Indoco Remedies standalone net profit rises 31.15% in the December 2021 quarter
 ( Results - Announcements 01-Feb-22   12:04 )
  Indoco Remedies gains after Q3 PAT soars 169% YoY
 ( Hot Pursuit - 09-Feb-21   13:00 )
  Indoco Remedies Ltd leads gainers in 'A' group
 ( Hot Pursuit - 01-Feb-22   12:01 )
Other Stories
  Board of Delhivery approves alteration in capital clause of MoA
  05-Jul-24   19:32
  J B Chemicals & Pharmaceuticals appoints director
  05-Jul-24   19:30
  Infosys announces resignation of senior management personnel
  05-Jul-24   19:22
  JLR Q1 FY25 retail sales up 9% on YoY basis
  05-Jul-24   19:08
  Bajaj Auto launches world's first CNG motorcycle 'Freedom'
  05-Jul-24   18:59
  Agenda for board meeting of Power Grid Corporation of India
  05-Jul-24   18:46
  Board of Bank of Baroda approves raising additional capital up to Rs 7,500 cr in FY25
  05-Jul-24   18:06
  Vipul to hold board meeting
  05-Jul-24   17:15
  Markobenz Ventures to convene board meeting
  05-Jul-24   17:15
  Dhanashree Electronics to declare Quarterly Result
  05-Jul-24   17:15
Back Top